Target Name: DPYSL3
NCBI ID: G1809
Review Report on DPYSL3 Target / Biomarker Content of Review Report on DPYSL3 Target / Biomarker
DPYSL3
Other Name(s): CRMP-4 | DPYL3_HUMAN | Dihydropyrimidinase-related protein 3 | Dihydropyrimidinase like 3, transcript variant 1 | DPYSL3 variant 2 | DRP3 | DPYSL3 variant 1 | Unc-33-like phosphoprotein | LCRMP | collapsin response mediator protein 4 long | Dihydropyrimidinase-related protein 3 isoform LCRMP-4 | ULIP protein | Collapsin response mediator protein 4 | Dihydropyrimidinase like 3, transcript variant 2 | CRMP4 | testicular secretory protein Li 7 | unc-33-like phosphoprotein 1 | Dihydropyrimidinase-Like 3 | ULIP | DRP-3 | Dihydropyrimidinase-related protein 3 (isoform 1) | ULIP-1 | Dihydropyrimidinase-related protein 3 (isoform 2) | dihydropyrimidinase like 3 | Unc-33-like phosphoprotein 1 | dihydropyrimidinase-related protein 3

DPYSL3: Insulin Secretion and Other Physiological Processes

DPYSL3 (CRMP-4) is a protein that is expressed in various tissues throughout the body, including the liver, pancreas, and gastrointestinal tract. It is a member of the CCAAT/enhancer-binding protein (CBP) family, which is a group of transcription factors that play a crucial role in the regulation of gene expression.

DPYSL3 is known for its role in the regulation of insulin secretion from the pancreas. It is a key transcription factor that is activated by insulin, and it has been shown to play a role in the regulation of pancreatic ductal secretion (PDSS) - the release of insulin from the pancreas into the bloodstream.

In addition to its role in insulin secretion,DPYSL3 is also involved in the regulation of a variety of other physiological processes in the body. For example, it is expressed in the liver, and has been shown to play a role in the regulation of glucose metabolism. It is also expressed in the gastrointestinal tract, and has been shown to play a role in the regulation of satiety and appetite.

DPYSL3 is a potential drug target (or biomarker) because of its involvement in the regulation of insulin secretion and other physiological processes. There is ongoing research into the use of drugs that target DPYSL3 as a treatment for a variety of conditions, including diabetes, obesity, and gastrointestinal diseases.

In addition to its potential as a drug target,DPYSL3 is also a valuable research tool for scientists who are studying the role of this protein in various biological processes. Researchers have used a variety of techniques to study the behavior of DPYSL3, including RNA sequencing, immunofluorescence, and biochemical assays.

Overall,DPYSL3 is a protein that is expressed in various tissues throughout the body and is involved in the regulation of insulin secretion, as well as a variety of other physiological processes. It is a potential drug target (or biomarker) and a valuable research tool for scientists who are studying its role in various biological processes.

Protein Name: Dihydropyrimidinase Like 3

Functions: Necessary for signaling by class 3 semaphorins and subsequent remodeling of the cytoskeleton. Plays a role in axon guidance, neuronal growth cone collapse and cell migration (By similarity)

The "DPYSL3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DPYSL3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

DPYSL4 | DPYSL5 | DQX1 | DR1 | DRAIC | DRAM1 | DRAM2 | DRAP1 | DRAXIN | DRB sensitivity-inducing factor complex | DRC1 | DRC3 | DRC7 | DRD1 | DRD2 | DRD3 | DRD4 | DRD5 | DRD5P1 | DRD5P2 | DRG1 | DRG2 | DRGX | DRICH1 | DROSHA | DRP2 | DSC1 | DSC2 | DSC3 | DSCAM | DSCAM-AS1 | DSCAML1 | DSCC1 | DSCR10 | DSCR4 | DSCR8 | DSCR9 | DSE | DSEL | DSEL-AS1 | DSG1 | DSG1-AS1 | DSG2 | DSG3 | DSG4 | DSN1 | DSP | DSP-AS1 | DSPP | DST | DST-AS1 | DSTN | DSTNP2 | DSTYK | DTD1 | DTD1-AS1 | DTD2 | DTHD1 | DTL | DTNA | DTNB | DTNB-AS1 | DTNBP1 | DTWD1 | DTWD2 | DTX1 | DTX2 | DTX2P1 | DTX2P1-UPK3BP1-PMS2P11 | DTX3 | DTX3L | DTX4 | DTYMK | Dual Specificity Mitogen-Activated Protein Kinase Kinase (MEK) | Dual specificity protein kinase (CLK) | Dual specificity protein tyrosine phosphatase | Dual-Specificity Tyrosine-(Y)-Phosphorylation Regulated Kinase 1 | DUBR | DUOX1 | DUOX2 | DUOXA1 | DUOXA2 | DUS1L | DUS2 | DUS3L | DUS4L | DUSP1 | DUSP10 | DUSP11 | DUSP12 | DUSP13 | DUSP14 | DUSP15 | DUSP16 | DUSP18 | DUSP19 | DUSP2 | DUSP21 | DUSP22 | DUSP23